Strongbridge Biopharma Total Assets 2014-2019 | SBBP

Strongbridge Biopharma total assets from 2014 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Strongbridge Biopharma Annual Total Assets
(Millions of US $)
2018 $170
2017 $104
2016 $138
2015 $97
2014 $24
2013 $0
Strongbridge Biopharma Quarterly Total Assets
(Millions of US $)
Q3 2019 $123
Q2 2019 $135
Q1 2019 $153
Q4 2018 $170
Q3 2018 $141
Q2 2018 $156
Q1 2018 $164
Q4 2017 $104
Q3 2017 $92
Q2 2017 $104
Q1 2017 $118
Q4 2016 $138
Q3 2016 $65
Q2 2016 $73
Q1 2016 $87
Q4 2015 $97
Q3 2015 $0
Q2 2015 $0
Q1 2015 $0
Q4 2014 $24
Q4 2013 $0
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.161B $0.018B
Strongbridge Biopharma PLC is a biopharmaceutical company which develops, acquires and commercializes product candidates that target rare diseases. Its product candidate consists of COR-003, is a cortisol inhibitor, for the treatment of endogenous Cushing's syndrome, COR-004 and COR-005 to treat acromegaly, BP-2001, the treatment of diabetes which are in different clinical trial. Strongbridge Biopharma PLC is based in Trevose, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.673B 16.20
CSL (CSLLY) Australia $95.121B 0.00
Gilead Sciences (GILD) United States $80.248B 9.94
Vertex Pharmaceuticals (VRTX) United States $60.330B 61.58
Biogen (BIIB) United States $51.985B 8.92
Illumina (ILMN) United States $48.657B 53.39
Regeneron Pharmaceuticals (REGN) United States $39.431B 17.27
Alexion Pharmaceuticals (ALXN) United States $24.652B 12.18
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.764B 0.00
Seattle Genetics (SGEN) United States $19.144B 0.00
Incyte (INCY) United States $16.904B 39.24
BioMarin Pharmaceutical (BMRN) United States $15.733B 0.00
Genmab (GNMSF) Denmark $14.047B 62.04
Galapagos (GLPG) Belgium $12.910B 33.26
Alnylam Pharmaceuticals (ALNY) United States $12.892B 0.00
Exact Sciences (EXAS) United States $12.329B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.338B 0.00
Sarepta Therapeutics (SRPT) United States $8.821B 0.00
BioNTech SE (BNTX) Germany $8.797B 0.00
Bio-Techne Corp (TECH) United States $8.353B 55.91
Guardant Health (GH) United States $7.945B 0.00
QIAGEN (QGEN) Netherlands $7.854B 25.61
Amarin (AMRN) Ireland $7.437B 0.00
Moderna (MRNA) United States $7.322B 0.00
Horizon Therapeutics Public (HZNP) Ireland $7.222B 18.36
ACADIA Pharmaceuticals (ACAD) United States $6.494B 0.00
Reata Pharmaceuticals (RETA) United States $6.349B 0.00
Exelixis (EXEL) United States $5.992B 16.85
ARGENX SE-ADR (ARGX) Netherlands $5.850B 0.00
Ascendis Pharma (ASND) Denmark $5.629B 0.00
Repligen (RGEN) United States $5.250B 95.14
Bluebird Bio (BLUE) United States $5.190B 0.00
China Biologic Products (CBPO) China $4.584B 25.82
MorphoSys AG (MOR) Germany $4.195B 0.00
Immunomedics (IMMU) United States $3.639B 0.00
Mirati Therapeutics (MRTX) United States $3.588B 0.00
NeoGenomics (NEO) United States $3.444B 183.28
Blueprint Medicines (BPMC) United States $3.435B 0.00
Adaptive Biotechnologies (ADPT) United States $3.381B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.377B 0.00
MyoKardia (MYOK) United States $3.301B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.241B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.223B 0.00
Emergent Biosolutions (EBS) United States $3.017B 29.97
Genmab (GMAB) Denmark $2.977B 6.13
Alkermes (ALKS) Ireland $2.927B 0.00
Halozyme Therapeutics (HALO) United States $2.865B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.831B 0.00
Zai Lab (ZLAB) China $2.817B 0.00
Acceleron Pharma (XLRN) United States $2.813B 0.00
UniQure (QURE) Netherlands $2.678B 0.00
Amicus Therapeutics (FOLD) United States $2.469B 0.00
Epizyme (EPZM) United States $2.323B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
Denali Therapeutics (DNLI) United States $2.247B 0.00
RA PHARMCTL INC (RARX) United States $2.210B 0.00
Myriad Genetics (MYGN) United States $2.134B 31.53
Zymeworks (ZYME) Canada $1.961B 0.00
Principia Biopharma (PRNB) United States $1.961B 0.00
Fate Therapeutics (FATE) United States $1.856B 0.00
Insmed (INSM) United States $1.807B 0.00
Akcea Therapeutics (AKCA) United States $1.807B 0.00
REGENXBIO (RGNX) United States $1.725B 0.00
Arvinas (ARVN) United States $1.712B 0.00
Ligand Pharmaceuticals (LGND) United States $1.602B 30.81
Alector (ALEC) United States $1.580B 0.00
Editas Medicine (EDIT) United States $1.541B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.475B 0.00
Intra-Cellular Therapies (ITCI) United States $1.414B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.362B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.343B 0.00
Coherus BioSciences (CHRS) United States $1.332B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Athenex (ATNX) United States $1.190B 0.00
Zealand Pharma (ZEAL) Denmark $1.177B 0.00
DBV Technologies S.A (DBVT) France $1.092B 0.00
Codexis (CDXS) United States $1.024B 0.00
Revance Therapeutics (RVNC) United States $1.001B 0.00
Mesoblast (MESO) Australia $0.996B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.950B 0.00
Pharming Group (PHGUF) Netherlands $0.926B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.902B 0.00
Heska (HSKA) United States $0.836B 213.66
ZIOPHARM Oncology Inc (ZIOP) United States $0.811B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.801B 6.74
GENFIT S.A (GNFT) France $0.763B 0.00
Adverum Biotechnologies (ADVM) United States $0.763B 0.00
Twist Bioscience (TWST) United States $0.762B 0.00
Vericel (VCEL) United States $0.753B 280.83
ANI Pharmaceuticals (ANIP) United States $0.749B 12.77
Cellectis S.A (CLLS) France $0.744B 0.00
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Intellia Therapeutics (NTLA) United States $0.716B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.713B 0.00
NantKwest (NK) United States $0.711B 0.00
Sorrento Therapeutics (SRNE) United States $0.698B 0.00
Retrophin (RTRX) United States $0.693B 0.00
Anika Therapeutics (ANIK) United States $0.652B 21.16
Cara Therapeutics (CARA) United States $0.652B 0.00
AC Immune SA (ACIU) Switzerland $0.652B 15.08
UROGEN PHARMA (URGN) United States $0.635B 0.00
Kadmon Holdings (KDMN) United States $0.602B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Prothena (PRTA) Ireland $0.555B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.553B 0.00
Agenus (AGEN) United States $0.550B 0.00
Precision BioSciences (DTIL) United States $0.521B 0.00
BioDelivery Sciences (BDSI) United States $0.513B 0.00
Clovis Oncology (CLVS) United States $0.501B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.501B 0.00
Cel-Sci (CVM) United States $0.495B 0.00
Dynavax Technologies (DVAX) United States $0.484B 0.00
Bellus Health (BLU) Canada $0.478B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.456B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.435B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.419B 0.00
AnaptysBio (ANAB) United States $0.408B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.401B 2.77
Merus (MRUS) Netherlands $0.401B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.392B 0.00
Kindred Biosciences (KIN) United States $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.370B 0.00
PDL BioPharma (PDLI) United States $0.368B 9.20
Mersana Therapeutics (MRSN) United States $0.367B 0.00
Avid Bioservices (CDMO) United States $0.362B 0.00
Pfenex (PFNX) United States $0.361B 0.00
Puma Biotechnology (PBYI) United States $0.356B 0.00
Cue Biopharma (CUE) United States $0.353B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Stemline Therapeutics (STML) United States $0.349B 0.00
MannKind (MNKD) United States $0.349B 0.00
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
OSMOTICA PHARM (OSMT) United States $0.345B 0.00
Inovio Pharmaceuticals (INO) United States $0.344B 0.00
CytomX Therapeutics (CTMX) United States $0.335B 0.00
Cellular Biomedicine (CBMG) United States $0.330B 0.00
Compugen (CGEN) Israel $0.318B 0.00
Albireo Pharma (ALBO) United States $0.305B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
IVERIC Bio (ISEE) United States $0.291B 0.00
Geron (GERN) United States $0.284B 0.00
Kamada (KMDA) Israel $0.277B 8.11
Sutro Biopharma (STRO) United States $0.277B 0.00
ADMA Biologics Inc (ADMA) United States $0.271B 0.00
WAVE Life Sciences (WVE) Singapore $0.266B 0.00
Prometic Life Sciences (LMNL) Canada $0.262B 0.00
VBI Vaccines (VBIV) United States $0.260B 0.00
ChromaDex (CDXC) United States $0.259B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
Seres Therapeutics (MCRB) United States $0.242B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.231B 0.00
Exicure (XCUR) United States $0.229B 0.00
Novavax (NVAX) United States $0.228B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.224B 0.00
Affimed (AFMD) Germany $0.221B 0.00
Theratechnologies (THTX) Canada $0.220B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.218B 0.00
XOMA (XOMA) United States $0.212B 0.00
Cerecor (CERC) United States $0.211B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Five Prime Therapeutics (FPRX) United States $0.207B 0.00
Athersys (ATHX) United States $0.202B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.200B 0.00
Arbutus Biopharma (ABUS) Canada $0.199B 0.00
Fortress Biotech (FBIO) United States $0.198B 0.00
Spero Therapeutics (SPRO) United States $0.188B 0.00
Alcobra (ARCT) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.184B 0.00
Applied Genetic Technologies (AGTC) United States $0.180B 0.00
TELA Bio (TELA) United States $0.177B 0.00
CorMedix Inc (CRMD) United States $0.175B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.174B 0.00
Aptinyx (APTX) United States $0.169B 0.00
Selecta Biosciences (SELB) United States $0.169B 0.00
Palatin Technologies (PTN) United States $0.163B 4.44
ARAVIVE, INC (ARAV) United States $0.159B 0.00
PHASEBIO PHARMA (PHAS) United States $0.157B 0.00
Dyadic (DYAI) United States $0.156B 0.00
Windtree Therapeutics (WINT) United States $0.148B 0.00
Menlo Therapeutics (MNLO) United States $0.148B 0.00
Abeona Therapeutics (ABEO) United States $0.146B 0.00
Verastem (VSTM) United States $0.142B 0.00
VTv Therapeutics (VTVT) United States $0.140B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.131B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.124B 0.00
Arsanis (XFOR) United States $0.124B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.122B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.121B 6.23
Clearside Biomedical (CLSD) United States $0.121B 0.00
Aduro Biotech (ADRO) United States $0.119B 0.00
Happiness Biotech Group (HAPP) China $0.115B 0.00
Celyad SA (CYAD) Belgium $0.115B 0.00
Antibe Therapeutics (ATBPF) Canada $0.110B 0.00
OvaScience (MLND) United States $0.108B 0.00
Acorda Therapeutics (ACOR) United States $0.099B 0.00
SESEN BIO, INC (SESN) United States $0.098B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.097B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.095B 0.00
Synlogic (SYBX) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
Adocia (ADOCY) France $0.086B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.085B 0.00
Trevena (TRVN) United States $0.083B 0.00
Orgenesis (ORGS) United States $0.082B 5.31
Catabasis Pharmaceuticals (CATB) United States $0.082B 0.00
Prima BioMed (IMMP) Australia $0.080B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Vaccinex (VCNX) United States $0.079B 0.00
Checkpoint Therapeutics (CKPT) United States $0.076B 0.00
NewLink Genetics (NLNK) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.068B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.058B 0.00
Curis (CRIS) United States $0.057B 0.00
Idera Pharmaceuticals (IDRA) United States $0.056B 0.00
DiaMedica Therapeutics (DMAC) United States $0.051B 0.00
Soligenix (SNGX) United States $0.050B 0.00
Vascular Biogenics (VBLT) Israel $0.050B 0.00
AquaBounty Technologies (AQB) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.047B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.043B 0.00
Celldex Therapeutics (CLDX) United States $0.037B 0.00
BioCardia (BCDA) United States $0.037B 0.00
Celsion (CLSN) United States $0.037B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
Unum Therapeutics (UMRX) United States $0.036B 0.00
Entera Bio (ENTX) Israel $0.033B 0.00
Bionano Genomics (BNGO) United States $0.032B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Oncobiologics (OTLK) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.028B 0.00
AmpliPhi Biosciences (ARMP) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.025B 0.00
Stellar Biotechnologies (EDSA) Canada $0.025B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
Cesca Therapeutics (THMO) United States $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
TRACON Pharmaceuticals (TCON) United States $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.011B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.009B 0.00
BioPharmX (BPMX) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00